Laboratory of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences and Global COE Program, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.
J Pharm Biomed Anal. 2011 Jun 1;55(3):574-82. doi: 10.1016/j.jpba.2011.01.038. Epub 2011 Mar 1.
The need for a simple and high-throughput method for identifying the tertiary structure of protein pharmaceuticals has increased. In this study, a simple method for mapping the protein fold is proposed for use as a complementary quality test. This method is based on cross-linking a protein using a [bis(sulfosuccinimidyl)suberate (BS(3))], followed by peptide mapping by LC-MS. Consensus interferon (CIFN) was used as the model protein. The tryptic map obtained via liquid chromatography tandem mass spectroscopy (LC-MS/MS) and the mass mapping obtained via matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy were used to identify cross-linked peptides. While LC-MS/MS analyses found that BS(3) formed cross-links in the loop region of the protein, which was regarded as the biologically active site, sodium dodecyl-sulfate polyacrylamide gel electrophoresis demonstrated that cross-linking occurred within a protein molecule, but not between protein molecules. The occurrence of cross-links at the active site depends greatly on the conformation of the protein, which is determined by the denaturing conditions. Quantitative evaluation of the tertiary structure of CIFN was thus possible by monitoring the amounts of cross-linked peptides generated. Assuming that background information is available at the development stage, this method may be applicable to process development as a complementary test for quality control.
对于一种简单、高通量的蛋白质药物三级结构鉴定方法的需求日益增加。在本研究中,提出了一种用于蛋白质折叠图谱绘制的简单方法,可作为补充质量测试使用。该方法基于使用[双(磺基琥珀酰亚胺基)]辛二酸酯(BS(3))交联蛋白质,然后通过 LC-MS 进行肽图分析。以普通干扰素(CIFN)作为模型蛋白。通过液相色谱串联质谱(LC-MS/MS)获得的胰蛋白酶图谱和通过基质辅助激光解吸/电离飞行时间质谱获得的质量图谱用于鉴定交联肽。虽然 LC-MS/MS 分析发现 BS(3)在蛋白质的环区形成交联,这被认为是生物活性部位,但十二烷基硫酸钠聚丙烯酰胺凝胶电泳表明交联发生在蛋白质分子内部,而不是蛋白质分子之间。活性部位的交联发生很大程度上取决于蛋白质的构象,这取决于变性条件。通过监测生成的交联肽的量,对 CIFN 的三级结构进行定量评估成为可能。假设在开发阶段有背景信息可用,该方法可作为质量控制的补充测试,适用于工艺开发。